منابع مشابه
Automatic, unsupervised classification of dyskinesia in patients with Parkinsons Disease
One of the characteristic symptoms of patients with Parkinson Disease (PD) is a rigidity of movement. These symptoms disappear after administration of Levodopa. However, the long-term use of levodopa causes involuntary movements (dyskinesia). A proper diagnosis requires an automatic, unsupervised method for the detection and classification of levodopa induced dyskinesia. The main problem, howev...
متن کاملCabergoline for Cushing's disease: A case report.
como la mayor dosificación (> 400 mg/día) podría favorecer la aparición de un síndrome de Cushing11. En consecuencia, debe tenerse especial precaución al utilizar AM por su acción sobre el eje del cortisol, dada la posibilidad de producirse, en un mismo paciente, un síndrome de Cushing y una IS posterior al retirar el AM bruscamente12. En conclusión, dado que el AM es un fármaco comúnmente util...
متن کاملManual Therapy Choices: A General Approach to Parkinsons Disease
In treating dysfunction, it is normal for most therapists to use a variety of modalities and methods including myofascial release, muscle-energy techniques, positional-release techniques and many more. The assumption must be that different tools achieve different effects, and the ones we choose reflect our perception as to the needs of the individual and/or of the tissues involved. Sledgehammer...
متن کاملValvular Heart Disease in Patients with Prolactinomas on Cabergoline Treatment
Dopamine agonists are the first line treatment of prolactinomas and Parkinson’s disease. Has shown an association between the use of high doses of ergot dopamine agonists, cabergoline and pergolide, and development of clinically significant (moderate to severe) heart valve regurgitation, valvular thickening and retraction in patients with Parkinson’s disease [1,2]. Because of this, he has appea...
متن کاملRemission with Cabergoline in Adolescent Boys with Cushing’s Disease
Cabergoline is a long-acting dopamine receptor agonist used for treatment of patients with uncured Cushing's disease (CD) and, as a first-line treatment, was used in only limited numbers of patients. This report presents two adolescent boys with CD who were treated with cabergoline. Two adolescent boys with clinical and laboratory findings of CD are presented. No pituitary adenoma was detected ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology
سال: 1995
ISSN: 0028-3878,1526-632X
DOI: 10.1212/wnl.45.6.1233-b